caa a22 4500 445807997 CHVBK 20180317145202.0 cr unu---uuuuu 170323e20110901xx s 000 0 eng 10.1007/s00415-011-6143-5 doi (NATIONALLICENCE)springer-10.1007/s00415-011-6143-5 Advances in the treatment of chronic inflammatory demyelinating neuropathies in 2010 [Elektronische Daten] [P. Lozeron, D. Adams] Chronic inflammatory demyelinating polyneuropathy (CIDP) is an uncommon disease of the peripheral nerves. The diagnosis is based mainly on clinical presentation, cerebrospinal fluid (CSF) examination, and electrodiagnostic studies. Treatment of CIDP has at least two components: supportive care and specific therapy including primarily steroids, intravenous immunoglobulins (IVIg), and plasmapheresis (PE). This review summarizes progress in the treatment of CIDP published during the last year. Springer-Verlag, 2011 CIDP nationallicence Treatment nationallicence IVIg nationallicence Steroids nationallicence Immunosuppressant nationallicence Lozeron P. Department of Neurology, Bicêtre University Hospital, AP-HP, 94275, Paris, France aut Adams D. Department of Neurology, Bicêtre University Hospital, AP-HP, 94275, Paris, France aut Journal of Neurology Springer-Verlag 258/9(2011-09-01), 1737-1741 0340-5354 258:9<1737 2011 258 415 https://doi.org/10.1007/s00415-011-6143-5 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s00415-011-6143-5 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Lozeron P. Department of Neurology, Bicêtre University Hospital, AP-HP, 94275, Paris, France aut NATIONALLICENCE 700 1- Adams D. Department of Neurology, Bicêtre University Hospital, AP-HP, 94275, Paris, France aut NATIONALLICENCE 773 0- Journal of Neurology Springer-Verlag 258/9(2011-09-01), 1737-1741 0340-5354 258:9<1737 2011 258 415 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer